Carer Health-Related Quality of Life: A Review of Modelling Considerations in National Institute for Health and Care Excellence Technology Appraisals (2000-2023) [0.03%]
照料者健康相关生活质量：英国国家卫生与护理卓越研究所技术评估（2000-2023）中建模考虑因素的回顾分析
Charlotte Ahmadu,Elise Evers,Johanna Lister et al.
Charlotte Ahmadu et al.
Objectives: Carer health-related quality of life (HRQoL) is increasingly used to support health technology assessments conducted by the National Institute for Health and Care Excellence (NICE). Modelling approaches and un...
The Economic and Clinical Impact of Recurring Automated Red Blood Cell Exchange to Manage Sickle Cell Disease in the UK [0.03%]
英国反复自动红血细胞交换对镰状细胞性疾病经济和临床影响的研究
Sarah M Medland,Jamie Bainbridge,Matthew Cawson et al.
Sarah M Medland et al.
Background/objective: Sickle cell disease (SCD) is a group of inherited health conditions affecting 7.74 million people worldwide. Regular automated red blood cell exchange (aRBCX) transfusions have been shown to improve ...
Estimating the Value of Adding 30 Days to the 180-Day Market Exclusivity of the First-to-File Generic Drug Manufacturer [0.03%]
对首家首仿药企市场独占期增加30天进行估价
Aylin Sertkaya,Zeid El-Kilani,Sean Klein et al.
Aylin Sertkaya et al.
Objectives: As an additional incentive to bringing more generic drugs to more markets sooner, our aim was to estimate the value of adding 30 days to the 180 days of market exclusivity currently granted to a qualifying fir...
A Budget Impact Model of Treatment of Primary Immune Deficiency with Immune Globulin Subcutaneous (Human), 20% (IgPro20) (Hizentra) [0.03%]
primary immune deficiency使用免疫球蛋白亚cutaneous（人类），20％（IgPro20）（Hizentra）的治疗预算影响模型
Rajiv Mallick,Rashad Carlton
Rajiv Mallick
Background: Primary immune deficiency (PID) comprises over 400 inborn errors of immunity. Immune globulin replacement therapy (IGRT) is the standard of care for many PID subtypes. Intravenous immunoglobulin (IVIG) is the ...
Cost Effectiveness of Recombinant Zoster Vaccine and Live-Attenuated Vaccine Against Herpes Zoster for Adults Aged 50 and Over in China [0.03%]
中国50岁以上成人带状疱疹减毒活疫苗和重组亚单位疫苗的有效性及成本效益分析研究
Lulu Liu,Qilin Zhang,Yamin Shu et al.
Lulu Liu et al.
Objective: Two vaccines against herpes zoster (HZ) are currently authorized for use in China: the adjuvanted recombinant zoster vaccine (RZV) and live-attenuated Zoster Vaccine Live (ZVL). The significant disparities in p...
Ellen M Howard,Marc Massetti,Gin Nie Chua et al.
Ellen M Howard et al.
Background: Isocitrate dehydrogenase-mutant (mIDH) gliomas are malignant central nervous system tumours. After initial resection, patients with mIDH gliomas with favourable prognosis may live without receiving oncologic t...
Individual Preference for Fecal Immunochemical Test Options among Younger Adults: A Discrete Choice Experiment [0.03%]
年轻成人粪便免疫化学试验选项的个人偏好：一项离散选择实验
Kailu Wang,Ho-Man Shum,Carrie Ho-Kwan Yam et al.
Kailu Wang et al.
Objectives: This study aims to quantify the preference of adults below 50 years of age for fecal immunochemical test (FIT) options as screening for colorectal cancer (CRC) and its disparities across different subgroups. ...
Willingness to Pay for Improved Quality of Services from Informal Health Providers in Urban Slums in Nigeria [0.03%]
尼日利亚城市贫民窟居民对改善非正规医疗服务质量的支付意愿
Obinna Onwujekwe,Godwin Uche Ezema,Chukwudi Nwokolo et al.
Obinna Onwujekwe et al.
Introduction: The shortage of formal healthcare providers in urban slums has resulted in the widespread presence of untrained informal healthcare providers (IHPs), who often deliver low-quality services. Integrating these...
Workneh Wondimagegn Azalu,Wudu Temesgen Jemberu,Bihonegn Wodajnew Taye et al.
Workneh Wondimagegn Azalu et al.
Background: Rabies remains a significant threat to both public health and economic stability across many developing countries. The challenge of effectively managing and preventing rabies is compounded by insufficient quan...
Identifying Potential Gaps in Care for Patients with Higher-Risk Myelodysplastic Syndromes in a Large US Health System [0.03%]
在美国大型医疗系统中识别较高风险骨髓增生异常综合征患者护理中的潜在缺口
Kristin J Moore,Nicole M Engel-Nitz,Peter McMahon et al.
Kristin J Moore et al.
Background: Higher-risk myelodysplastic syndromes (HR-MDS) may be difficult to diagnose because patients present with nonspecific signs and symptoms. This can prolong diagnosis, even though disease progression can occur q...